Paget's disease: ocular complications of disodium pamidronate treatment
O'Donnell, N.P.; Rao, G.P.; Aguis-Fernandez, A.
British Journal of Clinical Practice 49(5): 272-273
1995
ISSN/ISBN: 0007-0947 PMID: 7492469 Document Number: 446920
Three cases of uveitis associated with disodium pamidronate have been notified to the Committee for Safety of Medicines. Two new cases of bilateral anterior uveitis and episcleritis after administration of intravenous disodium pamidronate are described.
Document emailed within 1 workday
Related Documents
Wilczek, H.; Stĕpán, J. 1993: Paget's disease of bone and treatment with pamidronate Vnitrni Lekarstvi 39(7): 690-698Ghiringhelli, G.; Fogel, M.; Varela de Rodríguez, J.; Casco, C.; Mautelén, C.; Nusimovich, B. 1982: Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate Medicina 42(1): 16-20
De Vries, H.R.; Bijvoet, O.L. 1974: Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) Netherlands Journal of Medicine 17(6): 281-298
Muir, H.G.; Schabort, I.; Hough, F.S. 1987: Influence of disodium etidronate on Paget's disease of bone South African Medical Journal 72(7): 470-472
Pinel, B.; Cambon, C.; Thomine, J.M.; Cauvin, M.; Daragon, A.; Deshayes, P. 1984: Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate Revue du Rhumatisme et des Maladies Osteo-Articulaires 51(7-8): 417-418
Kotzmann, H.; Svoboda, T.; Bernecker, P.; Clodi, M.; Woloszczuk, W.; Niederle, B.; Waldhäusl, W.; Luger, A. 1994: Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism Wiener Klinische Wochenschrift 106(13): 422-425
Farre, J.M.; Delcambre, B. 1989: Functional consequences and complications of Paget's disease La Revue du Praticien 39(13): 1129-1136
Chakravorty, N.K. 1985: Neurological complications of Paget's disease of bone British Journal of Clinical Practice 39(9): 335-338
Body, G.; Granger, M.; Fetissoff, F.; Lansac, J. 1982: Paget's disease of the vulva associated with Paget's disease of the breast. Apropos of a case report. Review of the literature Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(7): 815-821
Pembrook, R.C.; Chung, C.H.; Carvallo, A.P. 1975: Effects of mithramycin and calcitonin in cardiovascular complications of Paget's disease of bone Connecticut Medicine 39(4): 209-214
Sugiura, S. 1978: Ocular complications of Behçet's disease Nursing Technique 24(11): 34-39
Kraj, M.; Pogłód, R.; Pawlikowski, J.; Maj, S.; Nasiłowska, B. 2000: Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. the results of the first 12 months of pamidronate therapy Acta Poloniae Pharmaceutica 57 Suppl: 113-116
Agrest, A. 1979: Treatment of Paget's disease Medicina 39(2): 275-276
Szmigiel, Z.; Jakubowska, U.; Szczepaniak, A.; Pikor-Daraz, I. 1977: Disodium cromoglycate (Intal) in the treatment of ulcerative colitis and the Leśniowski-Crohn disease Przeglad Lekarski 34(9): 743-746
Fleisch, H. 1975: Treatment of Paget's disease using diphosphosphonates Der Internist 16(8): 380-384
Zulkarneev, R.A. 1974: Treatment of Paget's disease with thyrocalcitonin Problemy Endokrinologii 20(1): 53-54
Reiner, M.; Jung, A.; Seiler, A.; Schenk, R.; Fleisch, H. 1975: Treatment of Paget's disease with phosphonates Schweizerische Medizinische Wochenschrift 105(50): 1701-1703
Mimura, K. 1985: Treatment of Paget's disease of bone Nihon Seikeigeka Gakkai Zasshi 59(8): 751-761
Eisinger, J.; D'Omezon, Y.; Recordier, A.M. 1973: Mithramycin in the treatment of hypercalcemia and Paget's disease Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(6): 457-460
Fromm, G.A.; Plantalech, L.; Casco, C.; González, D.; Mautalen, C.A. 1984: Treatment of Paget's bone disease with a bisphosphonate Medicina 44(3): 245-251